It’s been two years since Truvada, a drug that prevents HIV infection, got an enthusiastic seal of approval from the Centers for Disease Control and Prevention and the World Health Organization. Those two public-health juggernauts primarily recommended the daily pill, also known as pre-exposure prophylaxis or PrEP, for intravenous drug users and men who have sex with men.
The First Citywide Program to Get Black Women on PrEP Is Coming to Washington, D.C.
Premium Employers
